Methicillin-resistant Staphylococcus aureus (MRSA) infection is a major threat to human health due to its resistance to almost all classes of antibiotics. Discovery of novel antibacterial agents with new structures which combat the pathogens responsible for MRSA is urgent. In this study, three series of benzyl phenyl sulfide derivatives were designed and synthesized, and their antibacterial activity against eleven MRSA strains were evaluated. The results showed that two series of the synthetic compounds (5a-5l and 12p-12u) exhibit potent antibacterial activity against S. aureus and MRSA, with minimum inhibitory concentrations of 2-64 μg/mL. The structure-activity relationships are discussed and the mechanism of the antibacterial activity was shown to involve the destruction of the bacterial cell membrane. Finally, the MTT assay results suggest that the toxicity of compounds 5f and 5h is selective between bacteria and mammalian cells.
Introduction
Bacterial infection is a serious threat to human health. Methicillin-resistant Staphylococcus aureus (MRSA) was recently estimated to be responsible for 60-89% of nosocomial infections leading to 19,000 deaths and over $3 billion in health care costs per year in the United States alone [1] [2] [3] . The emergence of increasingly drug-resistant bacteria leads to the failure of clinical treatment with frequently-used antibiotics. It is a challenge to develop effective antibiotics because of the increasing resistance of antibiotic-resistant microorganisms. More potent and safer antimicrobial agents with novel scaffolds are urgently needed [4] .
Sulfides are common in natural materials such as garlic and chives [5, 6] . It has been reported that synthetic sulfides showed different pharmacological properties, including antitumor, antifungal, and antimicrobial activity [6] [7] [8] [9] [10] [11] . For example, benzyl phenyl sulfides have been reported to inhibit microbial growth [7, 12] . Meanwhile, stilbenoids have been widely reported to have antibacterial activity [13] [14] [15] [16] . The natural product cajaninstilbene acid (CSA, Fig. 1 ) has an antibacterial scaffold and we have identified several cajaninstilbene acid derivatives with excellent antibacterial activity against gram-positive bacteria, especially MRSA [15] . Benzyl phenyl sulfides exhibit structural properties similar to those of stilbenoids ( Fig. 1 ) and show antibacterial potential. It is a rational approach to replace the stilbene moiety in cajaninstilbene acid with benzyl phenyl sulfide.
The present study reports the design and synthesis of a series of novel benzyl phenyl sulfide derivatives, whose activity against various bacteria including eleven strains of MRSA was evaluated. The structure-activity relationships (SAR) and the preliminary antibacterial mechanism have been examined and are discussed. Among these compounds, two novel compounds (5f and 5h) with minimal toxicity against mammalian cells and promising activity against MRSA were identified. These authors contributed equally: Kuo Lu, Qi Chen * Jing Lin linjing_jnu@163.com * Wei-Min Chen twmchen@jnu.edu.cn
Result and discussion

Chemistry
The synthesis of benzyl phenyl sulfides 5a-5l is outlined in Fig. 2 . Briefly, benzyl phenyl sulfides 3a-3l were synthesized in two steps starting from compound 1 which was reacted with different thiols and then hydrolyzed to remove the acetyl group. Deprotection of 2a-2l with a base gave compounds 3a-3l. When reacted with isopentenyl bromide and sodium hydride in toluene, compounds 2a-2l were converted to 4a-4l. Compounds 4a-4l were hydrolyzed by a base and then acidified with 10% HCl to give 5a-5l.
Compounds 12p-12u were synthesized in seven steps, as shown in Fig. 3 . Compound 6 was synthesized from methyl 3-oxobutanoate according to the procedure of Chiarello [17] . The two free phenolic hydroxyls of compound 6 were protected by acetylation giving compound 7, which was then brominated with NBS to give compound 8. Compound 9 was obtained by the reaction of 8 with 4fluorobenzenethiol. Compound 9 was isoprenylated with isoprenyl bromide to give compound 10. The esters 11p-11u were obtained by the reaction of compound 10 with Fig. 1 The structures of benzyl phenyl sulfides, stilbenoids, and CSA Novel benzyl phenyl sulfide derivatives as antibacterial agents against methicillin-resistant. . . different halogenated alkanes or alchols, and hydrolysis of 11p-11u gave the target compounds 12p-12u.
MIC determination and SAR study
The minimum inhibitory concentration (MIC) of all synthetic compounds was evaluated in vitro by a serial dilution method [18] . The MIC is defined as the lowest concentration of antibacterial agent at which no growth of the strains is observed [19] . CSA and norfloxacin were used as positive controls. MIC values were determined with eleven strains of MRSA and one strain of methicillin-sensitive S. aureus, as well as three strains of gram-negative bacteria (Escherichia coli, Proteus vulgaris, Pseudomonas aeruginosa).
As shown in Table 1 , 3a-3l displayed little or no activity against most bacteria, indicating the importance of isoprenyl group. The MIC of 5a-5l was determined and values are summarized in Table 2 . Compared with 3a-3l, the antibacterial activity of 5a-5l against MRSA bacteria is greatly improved (2-16 folds change). This indicated that the introduction of isoprenyl group into compounds 3a-3l greatly enhances their antibacterial activity and electronwithdrawing substituents in the B ring contribute to the antibacterial activity. With electron-withdrawing substituents such as chlorine, fluorine, and trifluoromethyl in ring B, compounds 5d-5j have significant antibacterial activity and 5d, with an o-chlorophenyl B ring and 5h, with an m-fluorophenyl B ring, proved to be the most potent. Electron-donating substituents in the B ring are evidently not conducive to antibacterial activity. For example, 5k, which has m-methoxy and p-methoxy substituents in ring B, shows only weak antibacterial activity. Compounds 5a-5c, with electron-donating substituents such as methyl and methoxy in ring B show moderate activity. Compound 5l in which ring B has been replaced by a heterocycle were also synthesized. Its activities against bacteria were evaluated and are shown in Table 2 . Substitution with a heterocyclic ring leads to no obvious improvement in the antibacterial activity; the MIC values of 5l, containing a heterocyclic ring, are in the range of 4-32 μg ml −1 . Compounds 2a-2l and 4a-4l showed no activities against all the test strains at the concentration of 128 μg ml −1 (data not shown). This suggests that a free carboxyl group is essential to the antibacterial activity and indeed, esterification of the carboxyl leads to loss of antibacterial activity.
It has been reported that the introduction of hydrophobic chains into compounds is beneficial to antibacterial activity [15] . Thus, in order to get more potent antibacterial agents and to comprehensively illuminate the structure-activity relationship of benzyl phenyl sulfides with antibacterial activity, hydrocarbon chains with 2-7 carbons were introduced at the p-position of the carboxyl group in ring A. Considering the starting material (4-fluorophenyl)methanethiol is commercially available, the p-fluoro substituent in B ring was retained for its contribution to the antibacterial activity. The activity of compounds 12p-12u against different bacterial strains was evaluated (Table 3 ) and a slight, 2-4 folds increase in the activity against bacteria was observed. With an n-heptyl at the p-position to the carboxyl group, 12u proved to be the most potent compound. However, as the number of carbon atoms was increased, the logP of the compounds increased and the solubility of the compounds decreased sharply. 12u proved to be poorly soluble in aqueous media. Lacking the free carboxyl, compounds 11p-11u show no antibacterial effect at a concentration of 128 μg ml −1 (data not shown), proving that the carboxyl group is essential for the antibacterial activity.
MTT assay
The effects of 5f and 5h on of cell viabilities were determined using mouse macrophage cell lines (RAW 264.7) and IC 50 values were shown in Table 4 . Compared with the nature product CSA, 5f, and 5h exhibited similar effects on cell viabilities, while their antibacterial ability improved 2-16 folds. Compared IC 50 values to MIC values, 5f and 5h show moderate selectivity between bacterial and mammalian cells. Novel benzyl phenyl sulfide derivatives as antibacterial agents against methicillin-resistant. . .
Bacterial membrane permeability
The cell membrane of bacteria is one of the main targets of antibiotics. Drugs that target the bacterial cell membrane often are effective against drug-resistant bacteria [20] [21] [22] . Propidium iodide (PI) is a dye that can pass through the membrane of compromised bacterial cells and which fluoresces upon binding to DNA, indicating membrane damage [23] [24] [25] . The ability of compounds 5 f and 5 h with good antibacterial activity against MRSA to penetrate the bacterial cell membrane was studied using a PI assay [23] . As can be seen from Fig. 4 , both compounds were efficient in penetrating the membranes of S. aureus at concentrations of 4 μg ml −1 and 8 μg ml −1 and are more effective than the positive control melittin, a peptide which is a cytoplasmic membrane pore-forming toxin [26, 27] . The compounds tested exhibit a concentrationdependent effect on the penetration of the bacterial cell membrane. The results suggest that this class of compounds is likely to kill bacteria by damaging its cytoplasmic membrane.
Conclusion
A series of benzyl phenyl sulfides were designed and synthesized. Their MICs against one methicillin-sensitive S. aureus, three-gram-negative bacteria strains, as well as eleven clinical isolated MRSA strains were also determined. The synthesized derivatives were potent against S. aureus and, especially against MRSA. The MIC values against MRSA of 5d, 5e, 5f, 5h, and 5j are in the range of 2-16 μg ml −1 . More importantly, 5h and 5j exhibit good selectivity for bacterial over mammalian cells. The preliminary antibacterial mechanism of benzyl phenyl sulfides derivatives was shown to involve destruction of the bacterial cell membrane. The structure-activity relationships of this class of derivatives were summarized, and is expected to be useful in the future design and modification of new benzyl phenyl sulfide derivatives as candidate antibacterial agents.
Experimental
All reagents were used as purchased without further purification. All solvents were dried before use according to 
General procedure for synthesis of compounds 2a-2l
Compound 1 (1.00 g, 3.10 mmol) and an aromatic thiol (3.70 mmol, 1.2 equiv) was dissolved in dry CH 2 Cl 2 (10 ml) and Et 3 N (0.88 ml, 6.33 mmol) was added to the solution. The reaction mixture was stirred at r.t. for 1 h with the reaction monitored by TLC. After the reaction was complete, the mixture was filtered and the filtrate was concentrated under reduced pressure. The crude compound was then dissolved in MeOH (10 ml), and K 2 CO 3 (1.14 g, 1.5 equiv) was added to the solution. The suspension was stirred at r.t. for 30 min and then the solvent was removed under reduced pressure. The residue was dissolved in H 2 O (10 ml), neutralized with 2 N HCl and extracted with CH 2 Cl 2 (3 × 10 ml). The combined organic extracts were washed with H 2 O (2 × 10 ml) and brine (2 × 10 ml), then dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated under reduced pressure to give a crude product which was purified on a silica-gel column to obtain compounds 2a-2l.
General procedure for synthesis of compounds 3a-3l
Solid KOH (5 equiv) was added to a solution of 2a-2l (200 mg) in a mixed MeOH and H 2 O solvent (10 ml, MeOH: H 2 O, 5:1). The reaction mixture was refluxed for 6 h in an oil bath. After the reaction was complete, the mixture was quenched with ice water and acidified with 10% HCl. The precipitate was filtered and recrystallized from petroleum ether/EtOAc to obtain pure 3a-3l.
General procedure for synthesis of compounds 4a-4l
Compounds 2a-2l (3 mmol) were dissolved in dry toluene (20 ml). NaH (144 mg, 3.6 mmol, 60% in mineral oil) was added to the solution at 0°C. The reaction mixture was stirred at 50°C for 0.5 h, and then cooled to r.t. when isoprenyl bromide (745 mg, 4.5 mmol, 90%) was added dropwise. The reaction was stirred at 78°C for a further 2 h, then it was quenched by addition of ice water (20 ml). The mixture was extracted with EtOAc (2 × 10 ml) and the combined organic layer was washed with brine (2 × 10 ml), dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated under reduced pressure. The crude products were purified by silica-gel column to give compounds 4a-4l.
General produce for synthesis of compounds 5a-5l
Solid KOH (560 mg 10 mmol) was added to a solution of 4a-4l (2 mmol) in a mixture of MeOH and H 2 O (MeOH 8 ml, H 2 O 2 ml). The reaction mixture was refluxed for 6 h in an oil bath. After the reaction completed, the mixture was quenched by ice water and acidified with 10% HCl. The precipitate was filtered and recrystallized from petroleum ether/EtOAc to get pure 5a-5l. General procedure for synthesis of compounds 12p-12u
Preparation of compound 6 [17] . Methyl acetoacetate (20.0 g, 172.2 mmol) was added dropwise to a suspension of NaH (6.2 g, 258.4 mmol) in THF (100 ml) at 0°C. The solution was cooled to −78°C then a 2.5 M solution of n-BuLi (65.5 ml, 163.6 mmol) was added dropwise. The reaction mixture was warmed to ambient temperature and stirring was continued overnight. Then the mixture was acidified to pH 2 with 6 N HCl at 0°C and extracted with EtOAc (3 × 200 ml). The combined organic layer was dried over Na 2 SO 4 and concentrated in vacuo, and the residue was purified by flash chromatography to afford compound 6.
Preparation of compound 7: Ac 2 O (18 ml, 176 mmol) and TEA (24 ml, 176 mmol) were added to a mixture of compound 6 (8 g, 44 mmol) and DMAP (200 mg, 1.76 mmol) in CH 2 Cl 2 (100 ml). The reaction was stirred 1 h before being quenched with H 2 O. The mixture was then extracted with CH 2 Cl 2 (3 × 100 ml) and the combined organic layer was dried over Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash chromatography to afford compound 7.
Preparation of compound 8: NBS (1.8 g, 10 mmol) and BPO (20 mg) were added to a solution of compound 7 (4.4 g, 16.4 mmol) in CCl 4 . The reaction was refluxed for 3 h and then more NBS (1.8 g, 10 mmol) and BPO (20 mg) were added. The reaction was refluxed for another 3 h. The mixture was filtered after cooling to ambient temperature. The filtrate was concentrated in vacuo. The residue was purified by flash chromatography to afford compound 8.
Preparation of compound 9: 4-Fluorothiophenol (445 mg, 3.4 mmol) and TEA (0.8 ml, 5.8 mmol) were added to a solution of compound 8 (1.00 g, 2.9 mmol) in CH 2 Cl 2 (10 ml). The reaction was stirred for 2 h. Then the mixture was concentrated in vacuo and the residue was dissolved in MeOH (10 ml). K 2 CO 3 (1.20 g, 8.7 mmol) was added to the solution and the mixture was stirred overnight before being quenched with aqueous HCl (1 M), and then extracted with EtOAc (3 × 10 ml). The combined organic layer was dried over Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash chromatography to give compound 9.
Preparation of compound 10: NaH (260 mg, 6.49 mmol) was added to the suspension of compound 9 (2.00 g, 6.49 mmol) in toluene (60 ml) and the resulting mixture was stirred at 50°C for 4 h. The mixture was cooled to 35°C prior to the addition of isoprenyl bromide (1.32 g, 8.437 mmol) and then stirred overnight. The reaction was quenched with H 2 O and extracted with EtOAc (3 × 50 ml). The combined organic layer was dried over Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash chromatography to obtain compound 10.
General procedure for preparation of 11p, 11r, 11s, 11t: NaH (50.6 mg, 1.26 mmol) was added to a solution of compound 10 (300 mg, 0.97 mmol) in DMF (5 ml), and the mixture was stirred for 1 h. Then alkyl halide (1.45 mmol) was added to the mixture dropwise, the reaction was stirred for 3 h and was then quenched with H 2 O. The mixture was extracted with EtOAc (3 × 10 ml). The combined organic layer was dried over Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash chromatography giving compounds 11p, 11r, 11s and 11t.
General procedure for preparation of compounds 11q and 11u: A mixture of compound 10 (300 mg, 0.78 mmol), PPh 3 (354 mg, 1.17 mmol) and alkyl alcohol (0.78 mmol) was dissolved in dry THF (3 ml). DIAD (236 mg, 1.17 mmol) was added to the solution dropwise, the reaction was stirred for 16 h and then quenched with H 2 O. The mixture was extracted with EtOAc (3 × 10 ml). The combined organic layer was dried over Na 2 SO 4 , concentrated in vacuo. The residue was purified by flash chromatography to afford compounds 11q and 11u.
General procedure for preparation of 12p-12u: KOH (80 mg, 2 mmol) was added to a solution of compounds 11p-11u (0.5 mmol) in MeOH (5 ml) and H 2 O (2 ml). The reaction mixture was refluxed overnight and then quenched with ice water and acidified with aqueous HCl (2 M). The mixture was extracted with EtOAc (3 × 10 ml). The combined organic layer was dried over Na 2 SO 4 and concentrated in vacuo. The residues were purified by crystallized from PE/EtOAc. The products were obtained as white solids. 
Bacterial strains and growth conditions
MIC determination
The MICs were determined using a slightly modified broth micro-dilution method by Wiegand et al. [18] . Stock solutions of test compounds were prepared in DMSO. Various concentrations of test compounds were serially diluted in sterile MHB to final volumes of 100 μl in 96-well plates. Each well was then inoculated with 100 μl of the test organism in MHB at a final concentration of 5 × 10 5 CFU ml. The MICs were defined as the lowest concentration of test compounds at which growth was inhibited after 16 h of incubation at 37°C [28] .
MTT assay
The MTT assay were performed as described before [29] . Briefly, the RAW264.7 cells were cultured in DMED medium which contains 10% fetal bovine serum and 2 mM L-glutamine and 100 units/ml penicillin/streptomycin. The cultures were maintained in an atmosphere of 5% CO 2 at 37°C. Cells were passaged at preconfluent densities using a solution containing 0.25% trypsin and 0.5 mM EDTA. Cells were seeded at a density of 5000 cells/well in a 96-well plate for 24 h. The test compounds were stored in DMSO and diluted in the medium before use. For each group, the final DMSO concentration was less than 0.1%. Cell viability was assessed on the basis of cellular conversion of MTT into a formazan product with DMSO after 24 h exposure to the test compounds. Absorbance was detected by a Gen5 Reader at 570 nm. The experiments were performed in five replicate wells for each compound or concentration with at least three experimental runs.
Membrane permeabilization assay
A single S. aureus colony was inoculated into LB broth and cultured overnight. The culture was diluted into fresh LB broth with a dilution of 1:100 and allowed to continue culturing for 6 h to reach the exponential phase. The cells were harvested by centrifuged (3500 rpm, 5 min, 4°C). The template was washed and resuspended in HEPES buffer (5 mM glucose, 5 mM HEPES, pH 7.2) in 1:1 ratio. PI was added to the culture to a final concentration of 10 μg ml −1 . Different concentrations of the test compounds (5h and 5f) were then added into the culture containing PI. 0.1% DMSO (vol/vol) was used as negative control. Fluorescence was monitored at an excitation wavelength of 530 nm and an emission wavelength of 590 nm. The uptake of PI was monitored by the increase in fluorescence for 10 min as an index of inner membrane permeabilization.
